<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03203967</url>
  </required_header>
  <id_info>
    <org_study_id>2017[1308]</org_study_id>
    <nct_id>NCT03203967</nct_id>
  </id_info>
  <brief_title>Epidural Morphine for Postoperative Analgesia After Total Knee Arthroplasty</brief_title>
  <official_title>Effect of Low-dose Epidural Morphine Combined With Single-injection Femoral Nerve Block on Postoperative Analgesia in Patients After Total Knee Arthroplasty</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Peking University First Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Peking University First Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Single femoral nerve blockade combined with patient-controlled intravenous analgesia are used
      for postoperative analgesia for patients after TKA in the hospital of the investigators.
      Although this method provides acceptable analgesia, the incidence of opioid-associated side
      effects is relatively high. Low-dose epidural morphine is commonly used in postoperative
      analgesia after cesarean section, and the effect of single dose morphine lasts more than 20
      hours, with low incidences of itching, nausea, vomiting, and respiratory depression. The
      investigators hypothesize that, for patients undergoing TKA, the addition of low-dose
      epidural morphine to single femoral nerve block and intravenous opioids can improve the
      postoperative analgesia, reduce the consumption of intravenous opioids and decrease
      opioid-associated side effects.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Total knee arthroplasty (TKA) is an important therapy for patients with serious knee
      osteoarthritis in order to improve quality of life and relieve pain. But a large number of
      patients who undergo this surgery experience moderate to severe postoperative pain.
      Previously, the investigators used single femoral nerve blockade combined with
      patient-controlled intravenous analgesia for postoperative analgesia for patients after TKA.
      Although this method provides acceptable analgesia, the incidence of opioid-associated side
      effects is relatively high. Low-dose epidural morphine is commonly used in postoperative
      analgesia after cesarean section, and the effect of single dose morphine lasts more than 20
      hours, with low incidences of itching, nausea, vomiting, and respiratory depression. The
      investigators hypothesize that, for patients undergoing TKA, the addition of low-dose
      epidural morphine to single femoral nerve block and intravenous opioids can improve the
      postoperative analgesia, reduce the consumption of intravenous opioids and decrease
      opioid-associated side effects.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 1, 2017</start_date>
  <completion_date type="Anticipated">May 30, 2018</completion_date>
  <primary_completion_date type="Anticipated">April 30, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Percent of patients with moderate to severe pain (Numeric Rating Scale pain score of 4 or higher)</measure>
    <time_frame>Until 48 hours after surgery.</time_frame>
    <description>Pain severity is evaluated with Numeric Rating Scale (NRS, an 11-point scale where 0 = no pain and 10 = the worst pain) both at rest and with movement.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>NRS pain scores (at rest and with movement) at various timepoints after surgery</measure>
    <time_frame>At 6, 12, 24, 36 and 48 hours after surgery.</time_frame>
    <description>Assessed with NRS at 6, 12, 24, 36 and 48 hours after surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cumulative morphine consumption</measure>
    <time_frame>Until 48 hours after surgery.</time_frame>
    <description>Cumulative morphine consumption during 48 hours after surgery.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Recovery of motor function of the lower limb from blockade</measure>
    <time_frame>At the end of the surgery and at 0.5, 6, 12, 24, 36, 48 hours after surgery.</time_frame>
    <description>Modified Bromage scale (0 = no blockade: extended limb lift off the bed; 1 = flexion/extension at knee and ankle joint; 2 = no flexion/extension at knee or ankle joint; 3 = complete blockade).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to begin functional exercise and ground walking</measure>
    <time_frame>During hospital stay, up to 1 week after surgery.</time_frame>
    <description>Time to begin functional exercise and ground walking</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient's satisfaction with analgesia</measure>
    <time_frame>At 48 hours after surgery.</time_frame>
    <description>Evaluated in 5 scale, i.e., very satisfactory, satisfactory, neither satisfactory nor unsatisfactory, unsatisfactory, and very satisfactory.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of stay in hospital after surgery</measure>
    <time_frame>Until hospital discharge up to 30 days after surgery.</time_frame>
    <description>Length of stay in hospital after surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of postoperative complication</measure>
    <time_frame>Until 30 days after surgery.</time_frame>
    <description>Incidence of postoperative complication within 30 days after surgery.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The Western Ontario and McMaster Universities (WOMAC) Osteoarthritis Index</measure>
    <time_frame>At 30 days after surgery.</time_frame>
    <description>Evaluated with the Western Ontario and McMaster Universities (WOMAC) Osteoarthritis Index.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life (SF-12) at 30 days after surgery</measure>
    <time_frame>At 30 days after surgery.</time_frame>
    <description>Evaluated with Short-Form Health Survey-12 (SF-12) at 30 days after surgery.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">110</enrollment>
  <condition>Adult Patients</condition>
  <condition>Total Knee Arthroplasty</condition>
  <condition>Epidural Analgesia</condition>
  <condition>Femoral Nerve Block</condition>
  <condition>Analgesic Adverse Reaction</condition>
  <arm_group>
    <arm_group_label>Epidural morphine analgesia</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Epidural morphine (2 mg morphine in 5 ml normal saline) is administered through the epidural catheter at the end of surgery.
Single femoral nerve block is performed with 20 ml of 0.5% ropivacaine under the guidance of ultrasonography and nerve stimulator after surgery.
Intravenous morphine analgesia is provided with a patient-controlled analgesia pump which is established with 100 ml of 0.5 mg/mL morphine, programmed to deliver a 2 ml bolus with a lockout interval of 8-10 min and a background infusion of 0.5 mL/h.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Usual analgesia</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Epidural placebo (5 ml normal saline) is administered through the epidural catheter at the end of surgery.
Single femoral nerve block is performed with 20 ml of 0.5% ropivacaine under the guidance of ultrasonography and nerve stimulator after surgery.
Intravenous morphine analgesia is provided with a patient-controlled analgesia pump which is established with 100 ml of 0.5 mg/mL morphine, programmed to deliver a 2 ml bolus with a lockout interval of 8-10 min and a background infusion of 0.5 mL/h.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Epidural morphine</intervention_name>
    <description>2 mg of morphine (0.4 mg/ml morphine in 5 ml normal saline) is administered through the epidural catheter at the end of surgery.</description>
    <arm_group_label>Epidural morphine analgesia</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Epidural placebo</intervention_name>
    <description>5 ml normal saline is administered through the epidural catheter at the end of surgery.</description>
    <arm_group_label>Usual analgesia</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Single femoral nerve block</intervention_name>
    <description>Single femoral nerve block is performed with 20 ml 0.5% ropivacaine under the guidance of ultrasonography and nerve stimulator after surgery.</description>
    <arm_group_label>Epidural morphine analgesia</arm_group_label>
    <arm_group_label>Usual analgesia</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Intravenous morphine analgesia</intervention_name>
    <description>Intravenous morphine analgesia is provided with a patient-controlled analgesia pump which is established with 100 ml of 0.5 mg/ml morphine, programmed to deliver a 2 ml bolus with a lockout interval of 8-10 min and a background infusion of 0.5 ml/h.</description>
    <arm_group_label>Epidural morphine analgesia</arm_group_label>
    <arm_group_label>Usual analgesia</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adult patients (age of 18 years or older, but less than 90 years);

          -  American Society of Anesthesiologists classification I-III;

          -  Scheduled to undergo unilateral TKA under combined spinal and epidural anesthesia.

        Exclusion Criteria:

          -  Age higher than 90 years old;

          -  Presence of any contraindication to neuraxial block or peripheral nerve block;

          -  Continuous use of opioid analgesics during the last month;

          -  Unable to understand Numeric Rating Scale for pain evaluation or existence of language
             barrier;

          -  Severe renal insufficiency (requirement of renal replacement therapy);

          -  History of asthma;

          -  Recruited in another clinical trials.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dong-Xin Wang, MD,PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Peking University First Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Dong-Xin Wang, MD,PhD</last_name>
    <phone>8610-83572784</phone>
    <email>wangdongxin@hotmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Zhao-Ting Meng, MD</last_name>
    <phone>8610-83572460</phone>
    <email>526589053@qq.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Peking University First Hospital</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100034</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dong-Xin Wang, MD, PhD</last_name>
      <phone>8610 83572784</phone>
      <email>wangdongxin@hotmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Zhao-Ting Meng, MD</last_name>
      <phone>8610 83572460</phone>
      <email>526589053@qq.com</email>
    </contact_backup>
    <investigator>
      <last_name>Zhao-Ting Meng, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <reference>
    <citation>Lamplot JD, Wagner ER, Manning DW. Multimodal pain management in total knee arthroplasty: a prospective randomized controlled trial. J Arthroplasty. 2014 Feb;29(2):329-34. doi: 10.1016/j.arth.2013.06.005. Epub 2013 Jul 11.</citation>
    <PMID>23850410</PMID>
  </reference>
  <reference>
    <citation>Dong CC, Dong SL, He FC. Comparison of Adductor Canal Block and Femoral Nerve Block for Postoperative Pain in Total Knee Arthroplasty: A Systematic Review and Meta-analysis. Medicine (Baltimore). 2016 Mar;95(12):e2983. doi: 10.1097/MD.0000000000002983. Review.</citation>
    <PMID>27015172</PMID>
  </reference>
  <reference>
    <citation>Pulos N, Sheth N. Perioperative pain management following total joint arthroplasty. Ann Orthop Rheumatol. 2014;2(3):1029.Google Scholar</citation>
  </reference>
  <reference>
    <citation>Capdevila X, Barthelet Y, Biboulet P, Ryckwaert Y, Rubenovitch J, d'Athis F. Effects of perioperative analgesic technique on the surgical outcome and duration of rehabilitation after major knee surgery. Anesthesiology. 1999 Jul;91(1):8-15.</citation>
    <PMID>10422923</PMID>
  </reference>
  <reference>
    <citation>Singelyn FJ, Deyaert M, Joris D, Pendeville E, Gouverneur JM. Effects of intravenous patient-controlled analgesia with morphine, continuous epidural analgesia, and continuous three-in-one block on postoperative pain and knee rehabilitation after unilateral total knee arthroplasty. Anesth Analg. 1998 Jul;87(1):88-92.</citation>
    <PMID>9661552</PMID>
  </reference>
  <reference>
    <citation>Wang H, Boctor B, Verner J. The effect of single-injection femoral nerve block on rehabilitation and length of hospital stay after total knee replacement. Reg Anesth Pain Med. 2002 Mar-Apr;27(2):139-44.</citation>
    <PMID>11915059</PMID>
  </reference>
  <reference>
    <citation>Bonica J. Postoperative pain. In: Bonica J, editor. The Management of Pain. 2nd ed. Philadelphia: Lea &amp; Febiger; 1990. p. 461-80.</citation>
  </reference>
  <reference>
    <citation>Pang WW, Hsu TC, Tung CC, Hung CP, Chang DP, Huang MH. Is total knee replacement more painful than total hip replacement? Acta Anaesthesiol Sin. 2000 Sep;38(3):143-8.</citation>
    <PMID>11125689</PMID>
  </reference>
  <reference>
    <citation>Chughtai M, Jauregui JJ, Mistry JB, Elmallah RK, Diedrich AM, Bonutti PM, Delanois R, Mont MA. What Influences How Patients Rate Their Hospital After Total Knee Arthroplasty? Surg Technol Int. 2016 Apr;28:261-5.</citation>
    <PMID>27042784</PMID>
  </reference>
  <reference>
    <citation>Lavie LG, Fox MP, Dasa V. Overview of Total Knee Arthroplasty and Modern Pain Control Strategies. Curr Pain Headache Rep. 2016 Nov;20(11):59. doi: 10.1007/s11916-016-0592-6. Review.</citation>
    <PMID>27655139</PMID>
  </reference>
  <reference>
    <citation>Seet E, Leong WL, Yeo AS, Fook-Chong S. Effectiveness of 3-in-1 continuous femoral block of differing concentrations compared to patient controlled intravenous morphine for post total knee arthroplasty analgesia and knee rehabilitation. Anaesth Intensive Care. 2006 Feb;34(1):25-30. Erratum in: Anaesth Intensive Care. 2016 May;44(3):428-9.</citation>
    <PMID>16494145</PMID>
  </reference>
  <reference>
    <citation>Tierney E, Lewis G, Hurtig JB, Johnson D. Femoral nerve block with bupivacaine 0.25 per cent for postoperative analgesia after open knee surgery. Can J Anaesth. 1987 Sep;34(5):455-8.</citation>
    <PMID>3664912</PMID>
  </reference>
  <reference>
    <citation>Weber A, Fournier R, Van Gessel E, Gamulin Z. Sciatic nerve block and the improvement of femoral nerve block analgesia after total knee replacement. Eur J Anaesthesiol. 2002 Nov;19(11):834-6.</citation>
    <PMID>12442936</PMID>
  </reference>
  <reference>
    <citation>Mansour NY, Bennetts FE. An observational study of combined continuous lumbar plexus and single-shot sciatic nerve blocks for post-knee surgery analgesia. Reg Anesth. 1996 Jul-Aug;21(4):287-91.</citation>
    <PMID>8837184</PMID>
  </reference>
  <reference>
    <citation>Sundarathiti P, Ruananukul N, Channum T, Kitkunasathean C, Mantay A, Thammasakulsiri J, Sodsee W. A comparison of continuous femoral nerve block (CFNB) and continuous epidural infusion (CEI) in postoperative analgesia and knee rehabilitation after total knee arthroplasty (TKA). J Med Assoc Thai. 2009 Mar;92(3):328-34.</citation>
    <PMID>19301724</PMID>
  </reference>
  <reference>
    <citation>Pöpping DM, Zahn PK, Van Aken HK, Dasch B, Boche R, Pogatzki-Zahn EM. Effectiveness and safety of postoperative pain management: a survey of 18 925 consecutive patients between 1998 and 2006 (2nd revision): a database analysis of prospectively raised data. Br J Anaesth. 2008 Dec;101(6):832-40. doi: 10.1093/bja/aen300. Epub 2008 Oct 22.</citation>
    <PMID>18945716</PMID>
  </reference>
  <reference>
    <citation>Duarte VM, Fallis WM, Slonowsky D, Kwarteng K, Yeung CK. Effectiveness of femoral nerve blockade for pain control after total knee arthroplasty. J Perianesth Nurs. 2006 Oct;21(5):311-6.</citation>
    <PMID>17027440</PMID>
  </reference>
  <reference>
    <citation>Salinas FV, Liu SS, Mulroy MF. The effect of single-injection femoral nerve block versus continuous femoral nerve block after total knee arthroplasty on hospital length of stay and long-term functional recovery within an established clinical pathway. Anesth Analg. 2006 Apr;102(4):1234-9.</citation>
    <PMID>16551930</PMID>
  </reference>
  <reference>
    <citation>Soto Mesa D, Del Valle Ruiz V, Fayad Fayad M, Cosío Carreño F, Blanco Rodríguez I, González Castaño R, Bermejo Alvárez MA. [Control of postoperative pain in knee arthroplasty: single dose femoral nerve block versus continuous femoral block]. Rev Esp Anestesiol Reanim. 2012 Apr;59(4):204-9. doi: 10.1016/j.redar.2012.02.013. Epub 2012 Apr 30. Spanish.</citation>
    <PMID>22551482</PMID>
  </reference>
  <reference>
    <citation>Singh SI, Rehou S, Marmai KL, Jones PM. The efficacy of 2 doses of epidural morphine for postcesarean delivery analgesia: a randomized noninferiority trial. Anesth Analg. 2013 Sep;117(3):677-85. doi: 10.1213/ANE.0b013e31829cfd21. Epub 2013 Aug 6.</citation>
    <PMID>23921652</PMID>
  </reference>
  <reference>
    <citation>Marroquin B, Feng C, Balofsky A, Edwards K, Iqbal A, Kanel J, Jackson M, Newton M, Rothstein D, Wong E, Wissler R. Neuraxial opioids for post-cesarean delivery analgesia: can hydromorphone replace morphine? A retrospective study. Int J Obstet Anesth. 2017 May;30:16-22. doi: 10.1016/j.ijoa.2016.12.008. Epub 2016 Dec 30.</citation>
    <PMID>28185794</PMID>
  </reference>
  <reference>
    <citation>Sundarathiti P, Thammasakulsiri J, Supboon S, Sakdanuwatwong S, Piangjai M. Comparison of continuous femoral nerve block (CFNB/SA) and continuous femoral nerve block with mini-dose spinal morphine (CFNB/SAMO) for postoperative analgesia after total knee arthroplasty (TKA): a randomized controlled study. BMC Anesthesiol. 2016 Jul 16;16(1):38. doi: 10.1186/s12871-016-0205-2.</citation>
    <PMID>27422406</PMID>
  </reference>
  <verification_date>June 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 30, 2017</study_first_submitted>
  <study_first_submitted_qc>June 28, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">June 29, 2017</study_first_posted>
  <last_update_submitted>June 28, 2017</last_update_submitted>
  <last_update_submitted_qc>June 28, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">June 29, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Peking University First Hospital</investigator_affiliation>
    <investigator_full_name>Dong-Xin Wang</investigator_full_name>
    <investigator_title>Professor and Chairman, Department of Anesthesiology and Critical Care Medicine</investigator_title>
  </responsible_party>
  <keyword>Adults</keyword>
  <keyword>Unilateral TKA</keyword>
  <keyword>Single femoral nerve block</keyword>
  <keyword>Low-dose epidural morphine</keyword>
  <keyword>Effect of postoperative analgesia</keyword>
  <keyword>Quality of life</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Agnosia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Morphine</mesh_term>
    <mesh_term>Ropivacaine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

